Yariv Houvras

Technik-/Wissenschafts-/F&E-Leiter bei XILIO THERAPEUTICS, INC.

Consumer Services

Health Technology

Profil

Dr. Yariv J.
Houvras is a Chief Medical Officer at Xilio Therapeutics, Inc. Dr. Houvras was previously employed as a SVP-Clinical & Translational Development by Tubulis GmbH.
He received his undergraduate degree from the University of Michigan and a doctorate degree from Icahn School of Medicine at Mount Sinai.

Aktive Positionen von Yariv Houvras

Unternehmen	Position	Beginn
XILIO THERAPEUTICS, INC.	Technik-/Wissenschafts-/F&E-Leiter	28.09.2026

Alle aktiven Positionen von Yariv Houvras

Ehemalige bekannte Positionen von Yariv Houvras

Unternehmen	Position	Ende
Tubulis GmbH Tubulis GmbH BiotechnologyHealth Technology Develops and manufactures antibody-drug conjugates with biophysical properties to treat cancer tumors	Corporate Officer/Principal	-

Sehen Sie sich die Erfahrung von Yariv Houvras im Detail an

Ausbildung von Yariv Houvras

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Yariv Houvras im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	4
University of Michigan University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Icahn School of Medicine at Mount Sinai Icahn School of Medicine at Mount Sinai Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Xilio Therapeutics, Inc. Xilio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops tumor-selective immuno-oncology therapies	Health Technology
Tubulis GmbH Tubulis GmbH BiotechnologyHealth Technology Develops and manufactures antibody-drug conjugates with biophysical properties to treat cancer tumors	Health Technology